Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 19041764.
- Also identified by DOI 10.1016/j.cmet.2008.10.009 and PMC identifier 5484540.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Thiazolidinediones (TZDs) are PPARgamma activators that exhibit vasculoprotective properties. To determine the vascular function of PPARgamma, we analyzed Tie2Cre/flox and SM22Cre/flox mice. Unexpectedly, both knockout strains exhibited a significant reduction of circadian variations in blood pressure and heart rate in parallel with diminished variations in urinary norepinephrine/epinephrine excretion and impaired rhythmicity of the canonical clock genes, including Bmal1. PPARgamma expression in the aorta exhibited a robust rhythmicity with a more than 20-fold change during the light/dark cycle. Rosiglitazone treatment induced aortic expression of Bmal1 mRNA, and ChIP and promoter assays revealed that Bmal1 is a direct PPARgamma target gene. These studies have uncovered a role for vascular PPARgamma as a peripheral factor participating in regulation of cardiovascular rhythms.
Medical subject headings
- Basic Helix-Loop-Helix Proteins
- Blood Pressure
- Circadian Rhythm
- Heart Rate
- PPAR gamma